ACS Offers Catalog of Hard-to-Find Products for Cancer Patients

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 7 No 8
Volume 7
Issue 8

ATLANTA--The American Cancer Society is offering a "magalog," part magazine, part catalog, for women recovering from breast cancer and other cancers that involve treatment-related hair loss. Known as tlc (tender loving care), the nonprofit publication was created by Lana Leavitt Rosenfeld, an ACS volunteer.

ATLANTA--The American Cancer Society is offering a "magalog," part magazine, part catalog, for women recovering from breast cancer and other cancers that involve treatment-related hair loss. Known as tlc (tender loving care), the nonprofit publication was created by Lana Leavitt Rosenfeld, an ACS volunteer.

The catalog offers helpful articles on cancer-related issues and a wide selection of fashionable, hard-to-find products for women with cancer. The Fall/Winter 1998 edition, available in September, will offer a new selection of turbans and hats, including an exclusive line of turbans in ultra suede and panne velvet, and an expanded line of affordable lightweight wigs.

For the first time, tlc has designed a soft stretch sleep cap trimmed with lace and ribbons and appliquéd with butterflies, with matching lace-trimmed nightgown with pockets for prostheses. Also new this season, an exclusive T-shirt designed with a built-in bra to wear during radiation treatment and for leisure time.

The catalog offers a selection of pocketed camisoles and teddies as well as pocketed bras, silicone prostheses, and latex and foam breast forms. Other special products include a "hat sizer" to make regular-sized hats fit heads with little or no hair and a wig/cap liner to protect sensitive scalps from scratchy wigs or hats.

To receive a free copy of tlc, call 800-850-9445; fax 800-757-9997; write tlc at 340 Poplar St. Hanover, PA 17333, or order on the Internet at www.cancer.org. To ensure privacy, tlc is mailed only upon request, and customers’ names will not be provided to anyone for any purpose.

Recent Videos
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.
Related Content